Effets du mois de ramadan sur la pression artérielle de patients hypertendus
##plugins.themes.academic_pro.article.main##
Abstract
Introduction: During Ramadan, repeated cycles of fasting might contribute to changes in blood pressure among hypertensive patients. Studies on the effects of fasting on the blood pressure of hypertensive patients are scarce and have provided inconclusive results.
Aim: To examine the effect of fasting on ambulatory blood pressure and heart rate in treated hypertensive subjects.
Methods: The study prospectively recruited 60 hypertensive patients between April and June 2019, followed up at the cardiology department of Habib Thameur Hospital of Tunis. A 24-hour pressure monitoring was carried out during two periods: prior to Ramadan and during the last ten days of Ramadan. We compared the average values of 24 hour, awake and asleep systolic and diastolic blood pressure and 24 hour, awake and asleep heart rate.
Results: We studied 40 women and 20 men; mean age was 58.4 years. 33% of the patients were diabetics, 42% dyslipidemics, 15% had coronaropathy. 45% of the patients were on monotherapy, 37% on dual therapy and 18% on a triple antihypertensive therapy. During Ramadan, 74% of the patients were taking the treatment once daily, 3% twice daily, and 23% three times per day. Average 24hour ambulatory blood pressure in the whole group was 129±17/74±10 mmHg before Ramadan and 128±17/73±9 mmHg during Ramadan (p>0.05). Daytime and nighttime mean values of systolic and diastolic blood pressure as well as mean values of heart rate were not different between both periods regardless of age, gender, medical history and lifestyle.
Conclusions: In this study, there were no significant changes in systolic and diastolic blood pressures as well as heart rate during the 2 periods.
Keywords:
Hypertension artérielle, Jeûne alimentaire, Ramadan, Mesure ambulatoire de la pression artérielle##plugins.themes.academic_pro.article.details##
References
- 1. Ababou M, Ababou R, El Maliki A. Le jeûne du Ramadan au Maroc : un dilemne pour les patients diabétiques et les soignants. Sci Soc Santé. 2008; 26: 79‑104. 2. Ramirez LA, Sullivan JC. Sex differences in hypertension: where we have been and where we are going. Am J Hypertens. 2018; 31: 1247‑54. 3. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39: 3021‑104. 4. Younus A, Aneni EC, Spatz ES, Osondu CU, Roberson L, Ogunmoroti O, et al. A systematic review of the prevalence and outcomes of ideal cardiovascular health in US and non-US populations. Mayo Clin Proc. 2016; 91: 649‑70. 5. Kapetanakis VV, Rudnicka AR, Wathern AK, Lennon L, Papacosta O, Cook DG, et al. Adiposity in early, middle and later adult life and cardiometabolic risk markers in later life; findings from the British regional heart study. PloS One. 2014; 9:12. 6. Kuwabara M, Kuwabara R, Niwa K, Hisatome I, Smits G, Roncal-Jimenez CA, et al. Different risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia according to level of Body Mass Index in Japanese and American subjects. Nutrients. 2018; 10: 1011. 7. Lee C-Y, Lin W-T, Tsai S, Hung Y-C, Wu P-W, Yang Y-C, et al. Association of parental overweight and cardiometabolic diseases and pediatric adiposity and lifestyle factors with cardiovascular risk factor clustering in adolescents. Nutrients. 2016; 8: 567. 8. Crawford AG, Cote C, Couto J, Daskiran M, Gunnarsson C, Haas K, et al. Prevalence of obesity, type II diabetes mellitus, hyperlipidemia, and hypertension in the United States: findings from the GE Centricity Electronic Medical Record database. Popul Health Manag. 2010; 13: 151‑61. 9. Biad A, Chibane A, Makhlouf L, Attif L, Lanasri L, Kessous S. Prévalence of diabetes and hypertension in the east of Algiers. J Hypertens 2010;28:318-9. 10. de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, et al. Diabetes and Hypertension: A position statement by the American Diabetes Association. Diabetes Care. 2017; 40: 1273‑84. 11. Egan BM, Li J, Qanungo S, Wolfman TE. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010. Circulation. 2013; 128: 29‑41. 12. Kannel WB. Hypertension: reflections on risks and prognostication. Med Clin North Am. 2009; 93: 541‑58. 13. Tuomilehto J, Elo J, Nissinen A. Smoking among patients with malignant hypertension. Br Med J Clin Res Ed. 1982;284: 1086. 14. Groppelli A, Giorgi DMA, Omboni S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking: J Hypertens. 1992; 10: 495‑9. 15. Madika A-L, Mounier-Vehier C. Tabac et pression artérielle : une relation complexe à mieux connaître. Presse Médicale. 2017; 46: 697‑702. 16. Wagner A, Arveiler D, Ruidavets JB, Cottel D, Bongard V, Dallongeville J, et al. Etat des lieux sur l'hypertension artérielle en France en 2007 : l'étude Mona Lisa. Bulletin Epidémiologique Hebdomadaire, 2008; 49 : 483-6 17. Samad F, Qazi F, Pervaiz MB, Kella DK, Mansoor M, Osmani BZ, et al. Effects of ramadan fasting on blood pressure in normotensive males. J Ayub Med Coll Abbottabad JAMC. 2015; 27: 338‑42. 18. Khosropanah S, Ashraf F, Handjani AM. The effect of one-day Ramadan fast on blood pressure of hyprtensive patients. Iran Heart J. 2003; 4: 39-43. 19. Akturk IF, Biyik I, Kocas C, Yalcin AA, Uzun F, Erturk M. The effect of ramadan fasting on blood pressure levels of hypertensive patients with combination therapy. Int J Cardiol. 2012; 8: 155. 20. Nematy M, Alinezhad-Namaghi M, Rashed MM, Mozhdehifard M, Sajjadi SS, Akhlaghi S, et al. Effects of Ramadan fasting on cardiovascular risk factors: a prospective observational study. Nutr J. 2012; 11: 69. 21. Perk G, Ghanem J, Aamar S, Ben-Ishay D, Bursztyn M. The effect of the fast of Ramadan on ambulatory blood pressure in treated hypertensives. J Hum Hypertens. 2001; 15(10): 723‑5. 22. Ramadan J. Does fasting during Ramadan alter body composition, blood constituents and physical performance? Med Princ Pract Int J Kuwait Univ Health Sci Cent. 2002;11: 41‑6. 23. Bouguerra R, Jabrane J, Maâtki C, Ben Salem L, Hamzaoui J, El Kadhi A, et al. La pratique du jeûne du mois de Ramadan chez le diabétique de type 2. Ann Endocrinol. 2006; 67: 54‑9. 24. Fakhrzadeh H, Larijani B, Sanjari M, Baradar-Jalili R, Amini MR. Effect of Ramadan fasting on clinical and biochemical parameters in healthy adults. Ann Saudi Med. 2003; 23: 223‑6. 25. Yarahmadi S, Larijani B, Bastanhagh MH, Pajouhi M, Baradar Jalili R, Zahedi F, et al. Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes. J Coll Physicians Surg--Pak JCPSP. 2003; 13: 329‑32. 26. Ural E, Kozdag G, Kilic T, Ural D, Åžahin T, Çelebi O, et al. The effect of Ramadan fasting on ambulatory blood pressure in hypertensive patients using combination drug therapy. J Hum Hypertens. 2008; 22: 208‑10. 27. Taoudi Benchekroun M, Roky R, Toufiq J, Benaji B, Hakkou F. Epidemiological study: chronotype and daytime sleepiness before and during Ramadan. Therapie. 1999; 54: 567‑72. 28. Bursztyn M, Mekler J, Wachtel N, Ben-Ishay D. Siesta and ambulatory blood pressure monitoring. Comparability of the afternoon nap and night sleep. Am J Hypertens. 1994; 7: 217‑21. 29. Landsberg L, Young JB. Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med. 1978; 298: 1295‑301. 30. Stokholm KH, Breum L, Astrup A. Cardiac contractility, central haemodynamics and blood pressure regulation during semistarvation. Clin Physiol Oxf Engl. 1991; 11: 513‑23. 31. Azizi Fereidoun. Research in Islamic Fasting and Health. Ann Saudi Med. 2002; 22: 186‑91.